• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Blood and urinary aggregator and inhibitor composition in controls and renal-stone patients from northeastern Thailand.

作者信息

Sriboonlue P, Prasongwattana V, Tungsanga K, Tosukhowong P, Phantumvanit P, Bejraputra O, Sitprija V

机构信息

Department of Biochemistry, Khon Kaen University, Thailand.

出版信息

Nephron. 1991;59(4):591-6. doi: 10.1159/000186649.

DOI:10.1159/000186649
PMID:1766498
Abstract

Renal-stone disease (RSD) is common in the rural communities of northeastern Thailand. We report the biochemical composition of blood and urine in 25 healthy city dwellers (G1), 12 healthy village dwellers (G2) and 25 village dwellers who had RSD (G3). They were male with a range of ages between 20 and 50 years and were free of renal failure, urinary infection, urinary obstruction and systemic illness. The results showed that hypocitraturia, hypokalemia and hypokaliuria were more common in the latter 2 groups. The 24-h urinary citrate excretion correlated significantly with urinary potassium in G3 cases (r = 0.704, p = 0.0002). After potassium chloride supplementation, serum and urinary potassium increased remarkably (p less than 0.003 and p = 0.002, respectively), whereas urinary citrate remained unchanged. Our results suggest that the predominant abnormality in our RSD patients were hypocitraturia and potassium deficiency and that these may be related.

摘要

相似文献

1
Blood and urinary aggregator and inhibitor composition in controls and renal-stone patients from northeastern Thailand.
Nephron. 1991;59(4):591-6. doi: 10.1159/000186649.
2
Urinary acidification in renal stone patients from northeastern Thailand.
J Urol. 1992 Feb;147(2):325-8. doi: 10.1016/s0022-5347(17)37227-0.
3
Seasonal changes in serum and erythrocyte potassium among renal stone formers from northeastern Thailand.泰国东北部肾结石患者血清及红细胞钾的季节性变化
Southeast Asian J Trop Med Public Health. 1993 Jun;24(2):287-92.
4
Urinary citrate excretion in patients with renal stone: roles of leucocyte ATP citrate lyase activity and potassium salts therapy.
Clin Chim Acta. 2002 Nov;325(1-2):71-8. doi: 10.1016/s0009-8981(02)00254-1.
5
Some aspects of citrate metabolism in renal-stone patients from northeastern Thailand.
J Med Assoc Thai. 1996 Nov;79(11):737-43.
6
Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.复发性钙结石患者低枸橼酸尿症的病因:聚焦于尿钾排泄
Am J Kidney Dis. 2006 Oct;48(4):546-54. doi: 10.1053/j.ajkd.2006.06.008.
7
Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis.在噻嗪类药物治疗钙结石性肾病期间使用柠檬酸钾作为钾补充剂。
J Urol. 1984 Mar;131(3):430-3. doi: 10.1016/s0022-5347(17)50438-3.
8
[Citrate and kidney stones].[柠檬酸盐与肾结石]
Ugeskr Laeger. 1993 Nov 22;155(47):3835-9.
9
Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.尿枸橼酸盐与肾结石病:枸橼酸碱治疗的预防作用
Arch Ital Urol Androl. 2009 Sep;81(3):182-7.
10
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.肾结石形成的尿液危险因素的饮食治疗。CLU工作组综述
Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105.

引用本文的文献

1
Evaluation of the chemical composition of nephrolithiasis using dual-energy CT in Southern Chinese gout patients.应用双能量 CT 对中国南方地区痛风患者肾结石化学成分进行评估。
BMC Nephrol. 2019 Jul 19;20(1):273. doi: 10.1186/s12882-019-1441-8.
2
Loss-of-function mutations of SCN10A encoding Na1.8 α subunit of voltage-gated sodium channel in patients with human kidney stone disease.电压门控钠离子通道α亚单位 SCN10A 基因失活突变与人类肾结石病。
Sci Rep. 2018 Jul 11;8(1):10453. doi: 10.1038/s41598-018-28623-3.
3
Association between human prothrombin variant (T165M) and kidney stone disease.
人凝血酶原变异(T165M)与肾结石病的关联。
PLoS One. 2012;7(9):e45533. doi: 10.1371/journal.pone.0045533. Epub 2012 Sep 19.
4
Evidence suggesting a genetic contribution to kidney stone in northeastern Thai population.有证据表明泰国东北部人群的肾结石存在遗传因素。
Urol Res. 2009 Jun;37(3):141-6. doi: 10.1007/s00240-009-0189-1. Epub 2009 Apr 22.
5
Orthosiphon versus placebo in nephrolithiasis with multiple chronic complaints: a randomized control trial.三叶苦(Orthosiphon)对比安慰剂治疗多发性慢性疾病合并肾结石:一项随机对照试验。
Evid Based Complement Alternat Med. 2009 Dec;6(4):495-501. doi: 10.1093/ecam/nem141. Epub 2007 Oct 25.
6
Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment.肾结石患者的肾小管细胞损伤与氧化应激及柠檬酸钾治疗的效果
Urol Res. 2005 Feb;33(1):65-9. doi: 10.1007/s00240-004-0444-4. Epub 2004 Nov 25.
7
Kidney stone inhibitors in patients with renal stones and endemic renal tubular acidosis in northeast Thailand.泰国东北部肾结石及地方性肾小管酸中毒患者的肾结石抑制剂
Urol Res. 2004 May;32(2):112-6. doi: 10.1007/s00240-003-0389-z. Epub 2004 Feb 3.
8
Urinary lithogenic and inhibitory factors in preterm neonates receiving either total parenteral nutrition or milk formula.接受全胃肠外营养或配方奶喂养的早产儿的尿结石形成和抑制因素。
Eur J Pediatr. 2003 Jul;162(7-8):481-487. doi: 10.1007/s00431-003-1209-8. Epub 2003 May 16.